Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: an immunoinformatics-based approach. | J Mol Model | 2023 | 36928431 | PubTator, text mining | PubMed |
| BARX1 promotes osteosarcoma cell proliferation and invasion by regulating HSPA6 expression. | J Orthop Surg Res | 2023 | 36927457 | PubTator, text mining | PubMed |
| Proteome of airway surface liquid and mucus in newborn wildtype and cystic fibrosis piglets. | Respir Res | 2023 | 36927357 | PubTator, text mining | PubMed |
| Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilization. | Commun Biol | 2023 | 36914713 | PubTator, text mining | PubMed |
| Simple, Fast, and Efficient Method for Derivation of Dermal Fibroblasts From Skin Biopsies. | Curr Protoc | 2023 | 36912580 | PubTator, text mining | PubMed |
| The role of gene encoding collagen secretion protein (SERPINH1) in the pathogenesis of a hypermobile type of Ehlers-Danlos syndrome. | Postepy Dermatol Alergol | 2023 | 36909907 | PubTator, text mining | PubMed |
| The gastrointestinal antibiotic resistome in pediatric leukemia and lymphoma patients. | Front Cell Infect Microbiol | 2023 | 36909730 | PubTator, text mining | PubMed |
| Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. | Mol Cancer | 2023 | 36906534 | PubTator, text mining | PubMed |
| On the Role of TATA Boxes and TATA-Binding Protein in Arabidopsis thaliana. | Plants (Basel) | 2023 | 36903861 | PubTator, text mining | PubMed |
| Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice. | Int J Mol Sci | 2023 | 36902446 | PubTator, text mining | PubMed |
| Psoriatic Arthritis: Pathogenesis and Targeted Therapies. | Int J Mol Sci | 2023 | 36902329 | PubTator, text mining | PubMed |
| Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles? | Int J Mol Sci | 2023 | 36902314 | PubTator, text mining | PubMed |
| Prognostic Value of EMT Gene Signature in Malignant Mesothelioma. | Int J Mol Sci | 2023 | 36901697 | PubTator, text mining | PubMed |
| Glycomic, Glycoproteomic, and Proteomic Profiling of Philippine Lung Cancer and Peritumoral Tissues: Case Series Study of Patients Stages I-III. | Cancers (Basel) | 2023 | 36900350 | PubTator, text mining | PubMed |
| Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy. | Nature | 2023 | 36890230 | PubTator, text mining | PubMed |
| Mechanobiology of cancer cell responsiveness to chemotherapy and immunotherapy: Mechanistic insights and biomaterial platforms. | Adv Drug Deliv Rev | 2023 | 36889646 | PubTator, text mining | PubMed |
| Identification of potential therapeutic intervening targets by in-silico analysis of nsSNPs in preterm birth-related genes. | PLoS One | 2023 | 36881567 | PubTator, text mining | PubMed |
| Identification of lncRNA-miRNA-mRNA networks in circulating exosomes as potential biomarkers for systemic sclerosis. | Front Med (Lausanne) | 2023 | 36873898 | PubTator, text mining | PubMed |
| Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective. | Cell Biosci | 2023 | 36871010 | PubTator, text mining | PubMed |
| Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years. | Front Immunol | 2023 | 36860854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=21